These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 6196637)

  • 1. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
    Miike T
    Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle histochemistry in congenital muscular dystrophy with central nervous system involvement.
    Nonaka I; Sugita H; Takada K; Kumagai K
    Muscle Nerve; 1982 Feb; 5(2):102-6. PubMed ID: 6461828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of type 2C muscle fibers in Duchenne muscular dystrophy.
    Nonaka I; Takagi A; Sugita H
    Muscle Nerve; 1981; 4(4):326-33. PubMed ID: 6166859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle regeneration and satellite cells in Fukuyama type congenital muscular dystrophy.
    Terasawa K
    Muscle Nerve; 1986 Jun; 9(5):465-70. PubMed ID: 3724791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of muscle fibers typing on Duchenne muscular dystrophy].
    Gao FQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):273-7, 316. PubMed ID: 1291247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital muscular dystrophy. A histochemical study with morphometric analysis on biopsied muscles.
    Kihira S; Nonaka I
    J Neurol Sci; 1985 Sep; 70(2):139-49. PubMed ID: 4056819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorescent microscopy study of biopsied muscles from infantile neuromuscular disorders.
    Miike T; Tamari H; Ohtani Y; Nakamura H; Matsuda I; Miyoshino S
    Acta Neuropathol; 1983; 59(1):48-52. PubMed ID: 6837268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electron microscopical study of the T-system in biopsied muscles from Fukuyama type congenital muscular dystrophy.
    Miike T; Ohtani Y; Tamari H; Ishitsu T; Nonaka I
    Muscle Nerve; 1984 Oct; 7(8):629-35. PubMed ID: 6543909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
    Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A female infant of mitochondrial myopathy with findings of active necrosis and regeneration of muscle fibers].
    Nagaura T; Sumi K; Nonaka I
    Rinsho Shinkeigaku; 1990 Apr; 30(4):432-8. PubMed ID: 2387114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital muscular dystrophy.
    Huang FL; Mak SC; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):165-9. PubMed ID: 10677931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
    Taniguchi M; Kurahashi H; Noguchi S; Fukudome T; Okinaga T; Tsukahara T; Tajima Y; Ozono K; Nishino I; Nonaka I; Toda T
    Hum Mol Genet; 2006 Apr; 15(8):1279-89. PubMed ID: 16531417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of connective tissue growth factor in progressive muscular dystrophy].
    Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscle structural proteins of the opaque fibers in Duchenne type muscular dystrophy].
    Uchino M; Araki S; Yoshida O; Uekawa K
    Rinsho Shinkeigaku; 1983 Aug; 23(8):706-10. PubMed ID: 6661873
    [No Abstract]   [Full Text] [Related]  

  • 18. Regeneration in Duchenne muscular dystrophy. A histological electron-microscopic and histochemical study.
    Mastaglia FL; Papadimitriou JM; Kakulas BA
    Proc Aust Assoc Neurol; 1969; 6():93-106. PubMed ID: 5349193
    [No Abstract]   [Full Text] [Related]  

  • 19. Fetal myosin immunoreactivity in human dystrophic muscle.
    Schiaffino S; Gorza L; Dones I; Cornelio F; Sartore S
    Muscle Nerve; 1986 Jan; 9(1):51-8. PubMed ID: 3513005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinnervation in Duchenne muscular dystrophy.
    Dubrovsky A; Taratuto AL
    Muscle Nerve; 1983 May; 6(4):299-302. PubMed ID: 6866009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.